Dietary Patterns and Cardiovascular Disease Prevention among Patients with Diabetes

被引：1

作者：

Ishikawa Y. ^{[1
]}

Sattler E.L.P. ^{[1
,2
]}

机构：

[1] Department of Foods and Nutrition, College of Family and Consumer Sciences, University of Georgia, 305 Sanford Dr, Athens, 30602, GA

[2] Department of Clinical and Administrative Pharmacy, College of Pharmacy, University of Georgia, R.C. Wilson Pharmacy, Room 270 O, 250 West Green Street, Athens, 30602, GA

来源：

Current Nutrition Reports | 2017年 / 6卷 / 4期

基金：

美国国家卫生研究院;

关键词：

Cardiovascular diseases; Diabetes; Dietary Approaches to Stop Hypertension; Dietary patterns; Mediterranean diet;

D O I：

10.1007/s13668-017-0220-z

中图分类号：

学科分类号：

摘要：

Purpose of Review: This review summarizes the most recent literature on dietary patterns and their effects on cardiovascular health among patients with diabetes. Recent Findings: Studies identified examined low-fat, low-carbohydrate, low-glycemic index, Dietary Approaches to Stop Hypertension (DASH), and Mediterranean dietary patterns. A limited number of short-term studies showed that intake of low-fat, low-carbohydrate, and low-glycemic index dietary patterns reduced body weight and blood pressure among individuals with diabetes. Short-term consumption of the DASH dietary pattern reduced blood pressure, low-density lipoprotein cholesterol, and triglyceride levels in patients with diabetes. Most convincing evidence supports the effectiveness of Mediterranean dietary patterns in cardiovascular disease prevention by reducing cardiovascular risk factors and mortality among patients with diabetes, as supported by a prospective cohort study, randomized controlled trials, and meta-analyses. Summary: Among the dietary patterns identified, Mediterranean dietary patterns should be considered as primary nutritional recommendation for cardiovascular disease prevention among individuals with diabetes. © 2017, Springer Science+Business Media, LLC.

引用

页码：299 / 306

页数：7

共 66 条

[1]

Feigin V., Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015, Lancet, 388, 10053, pp. 1459-1544, (2016)

[2]

Stewart J., Manmathan G., Wilkinson P., Primary prevention of cardiovascular disease: a review of contemporary guidance and literature, JRSM Cardiovasc Dis, 6, (2017)

[3]

Fihn S.D., Gardin J.M., Abrams J., Berra K., Blankenship J.C., Dallas A.P., Et al., 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography

[4]

Anderson J.L., Adams C.D., Antman E.M., Bridges C.R., Califf R.M., Casey D.E.J., Et al., 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non–ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, Circulation, 127, pp. e663-e828, (2013)

[5]

Eckel R.H., Jakicic J.M., Ard J.D., Hubbard V.S., de Jesus J.M., Lee I.-M., AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology American/Heart Association Task Force on Practice Guidelines, Circulation. 2014

[6]

129 (25 Suppl, 2, pp. S76-S99, (2013)

[7]

Smith S.C.J., Benjamin E.J., Bonow R.O., Braun L.T., Creager M.A., Franklin B.A., Et al., AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation, Circulation, 124, pp. 2458-2473, (2011)

[8]

Yancy C.W., Jessup M., Bozkurt B., Butler J., Casey D.E.J., Drazner M.H., Et al., 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, Circulation, 128, pp. e240-e327, (2013)

[9]

Piepoli M.F., Hoes A.W., Agewall S., Albus C., Brotons C., Catapano A.L., Et al., 2016 European guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EA

[10]

Mathers C.D., Loncar D., Projections of global mortality and burden of disease from 2002 to 2030, PLoS Med, 3, 11, (2006)

← 1 2 3 4 5 6 7 →